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溶剂以及 9-13℃的条件下，用 10 mol%的催化剂和 10 mol%的水杨酸作为共催
化剂对不对称的 Michael 加成反应进行研究，取得了较佳的收率和立体选择性，
























Organophosphates are rarely incorporated into drug candidates despite the 
common appearance of phosphates of nucleosides, proteins, lipids, and 
carbohydrates in nature. Much of the reluctance to use these groups stems from their 
high charge and consequently the inability of these molecules to achieve high 
concentrations at the target site due to poor oral bioavailability in most biological 
fluids because of the presence of phosphatases. Amino acid phosphorodiamidate 
derivatives of d4T are anti-HIV prodrugs. In the past ten years, the filed of prodrugs 
for phosph(on)ates has evolved considerably. However, a prodrug for oral delivery is 
much still desired. Taking into account stability, byproduct toxicity, avoidance of 
stereoisomers, and validation in humans, the phosphonic diamides will play more 
important role in the future. On the basis of the processors, a series of amino acid 
phosphorodiamidates of d4T from PCl3 were synthesized. Furthermore, the 
compounds were also investigated using electrospray ionization multistage tandem 
mass spectrometry (ESI-MSn). It was found that two possible rearrangement 
mechanisms were acquired. And the formation mechanism of the ion at m/z 206 were 
also proposed. 
Organocatalysis has emerged as an extremely useful tool for the preparation of 
enantiomerically pure compounds in the past few years. Operation simplicity, high 
efficency, low-toxicity, atom economic, and high selectivity in many organocatalytic 
transformations made this methodology very attractive for the formation of 
enantiomerically pure compounds. In our work, A novel type of pyrrolidine-based 
chiral phosphoramidate has been synthesized in five steps and evaluated as 
organocatalyst in the direct asymmetric Michael addition of cyclohexanone to 
nitroolefins in the presence of ortho-hydroxybenzoic acid. The corresponding 
adducts are obtained with good chemical yields and high levels of 
diastereoselectivity and enantioselectivities (up to >99:1 dr and 98% ee). In view of 
the importance of the organocatalysts in the formation of carbon-carbon bond, we 


































符号 英文含义 中文含义 
AcOH Acetic acid 乙酸 
Ala Alanine 丙氨酸 
Cat Catalyst 催化剂 
AZT 3’-azido-2’,3'-deoxythymidine 叠氮脱氧胸苷 
DMSO Dimethylsulfoxide 二甲亚砜 
d4T 2,'3'-Didehydro-2’,3'-deoxythymidine 2’3’-双脱氢-2’,3’-双
脱氧胸苷 
DIPEA Diisopropylethylamine 二异丙基已胺 
EtOAc Ethyl acetate 乙酸乙酯 
ESI-MS Electrospray Ionization Mass 
Spectrometry 
电喷雾质谱 
Phe Phenylalanine 苯丙氨酸 
HIV Human immunodeficiency virus 艾滋病病毒 
HPLC High Performance Liquid 
Chromatography 
高效液相色谱 
HR-MS High Resolution Mass Spectrometry 高分辨质谱 
m-CPBA m-Chloroperbenzoic acid 间氯过氧苯甲酸 
NMR Nuclear Magnetic Resonance 核磁共振 
E3N Triethylamine 三乙胺 
Val Valine 缬氨酸 
Dr Diastereomeric Ratio 非对映异构体比例 
Ee Enantiomeric Excess 对映异构体过量 
TLC Thin Layer Chromatography 薄层色谱 
Phe Phenylalanine 苯丙氨酸 
Val Valine 缬氨酸 
Leu Leucine 亮氨酸 
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中心元素 [1]。正如诺贝尔将获得者 L .Todd 所说的那样：“哪里有生命，哪里
就有磷”[2]。生命体系中磷元素的含量约占人体中元素总量的 1.0 %；占肝脏总
重量的 0.2%；人脑总重量的 0.3 %；羟基磷灰石约占骨骼和牙齿总量的 87 %[3]；
作为生命遗传信息载体的核糖核酸（RNA）和脱氧核糖核酸（DNA）都是以磷





































谢产物 5’-单磷酸酯，然后再形成 BAD 才能发挥药效。现在所用的抗 HIV 药物
如：双脱氧肌苷 (ddI)、 叠氮胸苷 (AZT)和双脱氧胞苷 (ddC) ，这些化合物本
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